Legal status · United States
Is Thymosin Alpha-1 legal in the United States?
No. Thymosin Alpha-1 is not approved for any medical use in the United States; its classification is "Not fully approved; orphan-drug designation only". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Thymosin Alpha-1 in the United States at a glance
| Classification | Not fully approved; orphan-drug designation only |
|---|---|
| FDA approval status | Not FDA-approved (orphan status); approved in 30+ countries as Zadaxin |
| Evidence level | Moderate (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Thymosin Alpha-1 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
Thymosin Alpha-1 is being studied in registered clinical trials but has not received FDA marketing approval in the United States.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Thymosin Alpha-1 is
An immune-modulating thymic peptide approved in many countries for hepatitis and used as an immune adjuvant.
Thymosin Alpha-1 is a peptide originally isolated from the thymus that modulates T-cell function and innate immunity. Marketed as Zadaxin, it is approved in 30-plus countries for chronic hepatitis B and C and as an immune adjuvant, though it holds only orphan-drug status in the US.
Mechanism: Enhances T-cell maturation and function, modulates dendritic cells and cytokine signaling, and supports both adaptive and innate immune responses.
Regulatory history: Not FDA-approved (orphan status); approved in 30+ countries as Zadaxin
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Thymosin Alpha-1 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Thymosin Alpha-1 in other countries
Frequently asked questions
Is Thymosin Alpha-1 legal in the United States?
No. Thymosin Alpha-1 is not approved for any medical use in the United States; its classification is "Not fully approved; orphan-drug designation only". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Can I buy Thymosin Alpha-1 in the United States?
No approved product exists to buy. In the United States Thymosin Alpha-1 is classified as "Not fully approved; orphan-drug designation only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Thymosin Alpha-1 FDA approved?
No. FDA status: Not FDA-approved (orphan status); approved in 30+ countries as Zadaxin. Current US classification: "Not fully approved; orphan-drug designation only". Evidence level: Moderate.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Thymosin Alpha-1 live on its compound profile.
Thymosin Alpha-1 profileThis page is general information about the regulatory status of Thymosin Alpha-1 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.